Can T cells be too exhausted to fight back?

Science

Volumn 354, Issue 6316, 2016, Pages 1104-1105

  Turner, Stephen J ^a   Russ, Brendan E ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR;

ANTIBODY; ANTIGEN; CANCER; CELLS AND CELL COMPONENTS; GENE EXPRESSION; IMMUNE SYSTEM; IMMUNITY; PROTEIN; TUMOR;

CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELLULAR IMMUNITY; DIFFERENTIATION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; LIGAND BINDING; NEOPLASM; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; TUMOR REGRESSION; CD8+ T LYMPHOCYTE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

CD8-POSITIVE T-LYMPHOCYTES; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 85000788462     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aal3204     Document Type: Short Survey

References (15)

1. D. R. Sen et al., Science 354, 1165 (2016).
2. K. E. Pauken et al., Science 354, 1160 (2016).
3. D. M. Pardoll, Nat. Rev. Cancer 12, 252 (2012).
4. D. S. Shin, A. Ribas, Curr. Opin. Immunol. 33, 23 (2015).
5. H. Nishimura et al., Immunity 11, 141 (1999).
6. E. A. Tivol et al., Immunity 3, 541 (1995).
7. H. Dong et al., Nat. Med. 8, 1039 (2002).
8. O. Hamid et al., N. Engl. J. Med. 369, 134 (2013).
9. F. S. Hodi et al., N. Engl. J. Med. 363, 711 (2010).
10. A. Ribas et al., JAMA 315, 1600 (2016).
11. D. L. Barber et al., Nature 439, 682 (2006).
12. E. J. Wherry et al., Immunity 27, 670 (2007).
13. J. D. Buenrostro et al., Nat. Methods 10, 1213 (2013).
14. H. E. Ghoneim et al., Trends Mol. Med. 10.1016/j.molmed.2016.10.002 (2016).
15. F. Zhang et al., Mol. Ther. 22, 1698 (2014).